Clinicopathological significance of cyclin A, p27 and Skp2 in ovarian epithelial tumors

Basic and Applied Pathology

Volumn 2, Issue 2, 2009, Pages 53-58

  Heo, Jin Hyung ^a   Kim, Kwang Il ^a   Lee, Sun Young ^a   Kim, Tae Heon ^a   Kang, Haeyoun ^a   An, Hee Jung ^a  

^a CHA University School of Medicine   (South Korea)

Author keywords

Cyclin A; Ovarian neoplasm; P27Kip1 Protein; Skp2 Protein; Tissue array analysis

Indexed keywords

EID: 77955778568     PISSN: None     EISSN: 17559294     Source Type: Journal    
DOI: 10.1111/j.1755-9294.2009.01044.x     Document Type: Article

References (22)

1. Jemal A, Tiwari RC, Murray T. Cancer statistics. Cancer J Clin 2004, 54:8-29.
2. Brun J-L, Feyler A, Chene G. Long-term results and prognostic factors in patients with epithelial ovarian cancer. Gynecol Oncol 2000, 78:21-7.
3. Dobashi Y, Shoji M, Jiang SX, Kobayashi M, Kawakubo Y, Kameya T. Active cyclinA-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas. Am J Pathol 1998, 153:963-72.
4. Kyushima N, Watanabe J, Hata H, Jobo T, Kameya T, Kuramoto H. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables. J Cancer Res Clin Oncol 2002, 128:307-12.
5. Poikonen P, Sjostrom J, Amini RM, Villman K, Ahlgren J, Blomqvist C. Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer. Br J Cancer 2005, 93:515-9.
6. Reynisdottir I, Polyak K, Iavarone A, Massague J. Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF. Genes Dev 1995, 9:1831-45.
7. Bamberger AM, Riethdorf L, Milde LK, Bamberger CM, Thuneke I, Erdmann I, Schulte HM, Loning T. Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia. Virchows Arch 1999, 434:423-8.
8. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997, 3:222-5.
9. Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K, Akiyoshi T. p27 expression and gastric carcinoma. Nat Med 1997, 3:593.
10. Guo Y, Sklar GN, Borkowski A, Kyprianou N. Loss of the cyclin-dependent kinase inhibitor p27Kip1 protein in human prostate cancer correlates with tumor grade. Clin Cancer Res 1997, 3:2269-74.
11. Uta K, Nisar PM. p27: Tumor supressor and oncogene...?. Cell Res 2007, 17:832-3.
12. Zhang H, Kobayashi R, Galaktionov K, Beach D. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 1995, 82:915-25.
13. Nakayama KI, Nakayama K. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin Cell Dev Biol 2005, 16:323-33.
14. Xiong Y, Zhang H, Beach D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 1993, 7:1572-83.
15. Barboule N, Baldin V, Jozan S, Vidal S, Valette A. Increased level of p21 in human ovarian tumors is associated with increased expression of cdk2, cyclin A and PCNA. Int J Cancer 1998, 76:891-6.
16. Yoon BS. Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma. Eur J Obstet Hynecol Reprod Biol 2008, 136:110-5.
17. Chao Y, Shih YL, Chiu JH, Chau GY, Lui WY, Yang WK, Lee SD, Huang TS. Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res 1998, 58:985-900.
18. Hershko D, Bornstein G, Ben-Izhak O, Carrano A, Pagano M, Krausz MM, Hershko A. Inverse relation between levels of p27Kip1 and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Cancer (Phila) 2001, 91:1745-51.
19. Gstaiger M, Jordam R, Lim M, Catzavelos C, Mestan J, Slingerland J, Krek W. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci USA 2001, 98:5043-8.
20. Kudo Y, Kitajima S, Sato S, Miyauchi M, Ogawa I, Takata T. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res 2001, 61:7044-7.
21. Latres E, Chiarle R, Schulman BA, Pavletich NP, Pellicer A, Inghirami G, Pagano M. Role of the F-box protein Skp2 in lymphomagenesis. Proc Natl Acad Sci USA 2001, 98:2515-20.
22. Shigemasa K, Gu L, O'Brien TJ, Ohama K. Skp2 Overexpression Is a Prognostic Factor in Patients with Ovarian Adenocarcinoma. Clin Cancer Res 2003, 9:1756-63.